» Articles » PMID: 30417503

The Roles of Moonlight Ribosomal Proteins in the Development of Human Cancers

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2018 Nov 13
PMID 30417503
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

"Moonlighting protein" is a term used to define a single protein with multiple functions and different activities that are not derived from gene fusions, multiple RNA splicing, or the proteolytic activity of promiscuous enzymes. Different proteinous constituents of ribosomes have been shown to have important moonlighting extra-ribosomal functions. In this review, we introduce the impact of key moonlight ribosomal proteins and dependent signal transduction in the initiation and progression of various cancers. As a future perspective, the potential role of these moonlight ribosomal proteins in the diagnosis, prognosis, and development of novel strategies to improve the efficacy of therapies for human cancers has been suggested.

Citing Articles

Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions.

Caruso M, De Keersmaecker K Philos Trans R Soc Lond B Biol Sci. 2025; 380(1921):20230380.

PMID: 40045783 PMC: 11883432. DOI: 10.1098/rstb.2023.0380.


Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.

Longakit A, Urtatiz O, Luty A, Zhang C, Hess C, Yoo A Cancer Res Commun. 2025; 5(2):209-225.

PMID: 39804140 PMC: 11788999. DOI: 10.1158/2767-9764.CRC-24-0386.


Ribosomal rodeo: wrangling translational machinery in gynecologic tumors.

Filipek K, Penzo M Cancer Metastasis Rev. 2024; 44(1):13.

PMID: 39621173 PMC: 11611960. DOI: 10.1007/s10555-024-10234-2.


The Interplay Between the Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets.

Guerrieri A, Hattinger C, Marchesini F, Melloni M, Serra M, Ibrahim T Int J Mol Sci. 2024; 25(22).

PMID: 39596100 PMC: 11593864. DOI: 10.3390/ijms252212031.


DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family.

Wu S, Sun X, Hua R, Hu C, Qin L Discov Oncol. 2024; 15(1):333.

PMID: 39095628 PMC: 11297014. DOI: 10.1007/s12672-024-01204-9.